BMG6359F1370 - Common Stock

90.45 **-0.31 (-0.34%) **

After market: 90.45 0 (0%)

We assign a fundamental rating of **4** out of 10 to **NBR**. **NBR** was compared to 92 industry peers in the **Energy Equipment & Services** industry. Both the profitability and financial health of **NBR** have multiple concerns. **NBR** is growing strongly while it is still valued neutral. This is a good combination!

*Note: NBR has only limited data available, so a full analysis was not possible, which makes the total rating unfair.*

The Piotroski-F score of **NBR** is **5.00**. This is a neutral score and indicates average health and profitability for **NBR**.

The **Forward Price/Earnings Ratio** of **3.99** indicates a rather cheap valuation of **NBR**.

The low **PEG Ratio**, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

When comparing the **Enterprise Value to EBITDA** ratio of **NBR** to the average industry ratio of 5.48, **NBR** is valued rather cheaply.

When comparing the current price to the book value of **NBR**, we can conclude it is valued correctly. It is trading at **2.14** times its book value.

When comparing the price book ratio of **NBR** to the average industry price book ratio of 1.22, **NBR** is valued more expensive than its industry peers.

Price/Book (2.14) VS Industry: 25% outperformed.

129.71

0.18

Enterprise Value/ EBITDA (3.61) VS Industry: 79% outperformed.

120.47

1.85

Looking at the last year, **NBR** shows a very strong growth in **Revenue**. The Revenue has grown by **34.76%**.

When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.

Measured over the past 5 years, **NBR** shows a small growth in **Revenue**. The Revenue has been growing by **0.69%** on average per year.

Past | Future | ||||||
---|---|---|---|---|---|---|---|

5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |

EPS | N/A | N/A | 78.82% | 132.79% | 59.54% | 38.83% | N/A |

Revenue | 0.69% | -4.46% | 34.76% | 22.76% | 15.4% | 12.22% | N/A |

The Quick Ratio of **NBR** is much better than the industry average of **1.51**.

Compared to an average industry Altman-Z score of 1.77, **NBR** is in worse financial state than most of its industry peers. **83%** of its industry peers have a better Altman-Z score.

Debt/Equity (6.36) VS Industry: 3% outperformed.

16.18

0.00

Quick Ratio (1.61) VS Industry: 62% outperformed.

0.18

8.35

Current Ratio (1.87) VS Industry: 47% outperformed.

0.18

9.02

Altman-Z (0.42) VS Industry: 17% outperformed.

-7.36

10.89

No dividends for **NBR**!.

**NABORS INDUSTRIES LTD**

NYSE:NBR (5/26/2023, 7:04:00 PM)

After market: 90.45 0 (0%)**90.45**

**-0.31 (-0.34%) **

Chartmill FA Rating

GICS SectorEnergy

GICS IndustryGroupEnergy

GICS IndustryEnergy Equipment & Services

Earnings (Last)04-24 2023-04-24/amc

Earnings (Next)08-01 2023-08-01/amc

Inst Owners77.86%

Inst Owner Change6.78%

Ins Owners3.16%

Ins Owner Change7.76%

Market Cap862.85M

Analysts69.33

Price Target166.77 (84.38%)

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

Dividend Growth(5Y)-76.97%

DP-0.19%

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-576.1%

Min EPS beat(2)-1318.47%

Max EPS beat(2)166.28%

EPS beat(4)2

Avg EPS beat(4)-279.64%

Min EPS beat(4)-1318.47%

Max EPS beat(4)166.28%

Revenue beat(2)1

Avg Revenue beat(2)0.24%

Min Revenue beat(2)-0.28%

Max Revenue beat(2)0.75%

Revenue beat(4)3

Avg Revenue beat(4)0.97%

Min Revenue beat(4)-0.28%

Max Revenue beat(4)2.18%

PT rev (1m)-13.85%

PT rev (3m)-17.24%

EPS NQ rev (1m)-20.66%

EPS NQ rev (3m)-42.3%

EPS NY rev (1m)0%

EPS NY rev (3m)-7.02%

Revenue NQ rev (1m)-3.66%

Revenue NQ rev (3m)-6.77%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-2.21%

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | 3.99 | ||

P/S | 0.3 | ||

P/FCF | 4.19 | ||

P/OCF | 1.41 | ||

P/B | 2.14 | ||

P/tB | 2.14 | ||

EV/EBITDA | 3.61 |

EPS(TTM)-14.97

EYN/A

EPS(NY)22.68

Fwd EY25.08%

FCF(TTM)21.58

FCFY23.86%

OCF(TTM)64.34

OCFY71.13%

SpS300.26

BVpS42.22

TBVpS42.22

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | N/A | ||

ROE | N/A | ||

ROIC | 2.9% | ||

ROICexc | 3.27% | ||

ROICexgc | 3.27% | ||

OM | 5.32% | ||

PM | N/A | ||

GM | 38.71% |

ROICexgc(3y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc(3y)N/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.56%

GM growth 5Y2.44%

F-Score5

Asset Turnover0.61

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 6.36 | ||

Debt/FCF | 12.45 | ||

Debt/EBITDA | 3.14 | ||

Cap/Depr | 61.46% | ||

Profit Quality | N/A | ||

Current Ratio | 1.87 | ||

Quick Ratio | 1.61 | ||

Altman-Z | 0.42 |

F-Score5

WACC7.51%

ROIC/WACC0.44

Cap/Depr(3y)37.77%

Cap/Depr(5y)43%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

Growth

EPS 1Y78.82%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q118.26%

EPS Next Y132.79%

EPS Next 2Y59.54%

EPS Next 3Y38.83%

EPS Next 5YN/A

Revenue growth 1Y34.76%

Revenue growth 3Y-4.46%

Revenue growth 5Y0.69%

Revenue growth Q2Q37.04%

Revenue Next Year22.76%

Revenue Next 2Y15.4%

Revenue Next 3Y12.22%

Revenue Next 5YN/A

EBIT growth 1Y161.04%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year3188.33%

EBIT Next 3Y227.64%

EBIT Next 5YN/A

FCF growth 1Y6.61%

FCF growth 3Y-20.8%

FCF growth 5YN/A

OCF growth 1Y65.84%

OCF growth 3Y-9.88%

OCF growth 5Y51.49%

*Find stocks with similar Fundamental rating on the USA*

*Find more growth stocks the USA*

*Find the competitors with the best fundamentals on the USA*

*Find the competitors with the best valuation on the USA*

*Find the competitors with the best dividend on the USA*